The Pharmaceutical Research and Manufacturers Association writes us today in advance of World AIDS Day (December 1st) to let us know about the 97 HIV/AIDS medications currently in the research pipeline.
More from Joe My God
"Also of interest are personally tailored vaccine strategies, such as the one that made a splash earlier this month at AIDS Vaccine 2009, the annual meeting of the Global HIV Vaccine Enterprise, in Paris.
More from AIDS Treatment News
Elizabeth Pisani sorts through the conflicting press reports: I finally got around to combing through the full report of the trial in the New England Journal of Medicine.
More from Andrew Sullivan The Daily Dish
Courtesy of POZ.com:
An experimental treatment strategy involving a vaccine that is tailor-made from an HIV-positive person’s virus and immune system cells can reduce viral load and improve the function of the immune system, according to a presentation at the AIDS Vaccine 2009 conference in Paris on October 21 that was announced by the vaccine’s developer, [.
More from Gay Agenda
Last month an HIV vaccine showed effectiveness in trials, for the first time ever. Yet there is controversy over how well it really worked.
More from Real Jock
BBC News
Full results show AIDS vaccine is of modest helpThe Associated PressIt was the first time an AIDS vaccine was tested mostly in heterosexuals at average risk, and doctors have long known that how a person is exposed to HIV .
More from Google HIV News
Times LIVE
Questions about HIV vaccineTimes LIVEThe results also hint that the vaccine may work better in the general population than in those at higher risk of infection, such as gay men and intravenous .
More from Google HIV News
Two leading research institutions have joined forces for the development of an AIDS vaccine candidate.
More from HIVPlusMag.com
Experts raise concerns about the reliability of the trial of a vaccine which appeared to protect against HIV.
More from BBC Science News
News that the new HIV vaccine reduced the risk of infection by 31% is not true.
More from GCN.ie
A second analysis of trial data show that the vaccine, recently touted as lowering HIV infection risks by up to 30%, may not be effective after all.
More from HIVPlusMag.com
"This is the first positive signal of any degree of vaccine efficacy in humans, more than a quarter-century after scientists discovered the virus that causes AIDS.
More from AIDS Treatment News
Bil's in DC at the National Equality March, so I'm giving you all the list of what you need to read this week on Bilerico.
More from Bilerico
Men who have sex with men will be enrolled in 12 U.S. cities.
More from HIVPlusMag.com
The Covalent Immunology Foundation, who last week held a Manhattan event to promote their vaccine research, has rounded up some bold-face names to support their EndHIV.
More from Joe My God
Channel Africa
Global Health: HIV Vaccine Breakthrough?Global Voices Online (blog)... like in the early days of HIV/AIDS where gay men returned to unsafe sex when AZT, the first anti-HIV medicine produced and marketed, was made available.
More from Google HIV News
Voice of America
HIV Vaccine: With New Hope Comes The Potential Dangers of ComplacencyPharmiWeb.
More from Google HIV News
Experts say it may take a decade to figure out why this shot works while others have failed.
More from HIVPlusMag.com
Thailand wins praise for AIDS vaccine trialReutersThe trial vaccine was made using two failed products -- Sanofi-Pasteur's ALVAC canary pox/HIV vaccine and AIDSVAX, made by a San Francisco company called .
More from Google HIV News
Group says the research fosters hope but serves as a reminder that there is still no vaccine or cure for HIV.
More from HIVPlusMag.com